Trade Mark Journal No.2026/033 14 August 2026

UK00004420805 24 July 2026 (5)

CLARITY

International priority date claimed: 24 February 2026 (United States of America) (99668477)

Class 5: Pharmaceutical preparations for the treatment of Major Depressive Disorder and Excessive Daytime Sleepiness; Prescription medicines for the treatment of Major Depressive Disorder and Excessive Daytime Sleepiness.

Axsome Therapeutics, Inc.

Representative: Keltie LLP